Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

GlucoTrack Inc

GCTK ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.37

▲ +0.52%

Market Cap $3.89M · Vol 25.52K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.89M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

52.43

Momentum

Beta

0.50

vs Market

52W High

$14.11

97.40% below

52W Low

$0.25

44.25% above

Volume

25.52K

Avg 835.42K

P/B

1.25

Price-to-book

ROE

N/A

Return on equity

Free Float

88.93%

Public shares

Shariah Compliance8 STANDARDS

✗ GlucoTrack Inc (GCTK) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GCTK pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-14.99%

-30.56%

-45.16%

-77.73%

YTD

-90.51%

-93.58%

-99.98%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-19,388,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-281.60% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	1.25
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	10.58M

Technical Indicators

50-Day SMA	$0.41
200-Day SMA	$2.14
RSI (14)	52.43
Beta	0.50
52-Week High	$14.11
52-Week Low	$0.25

Volume Today	25.52K
Avg Daily Volume (30D)	835.42K
Relative Volume	0.03x
Volatility (10D)	221.33
Volatility (30D)	365.89
Free Float	88.93%

Analyst Consensus

N/A

Current Price $0.37

Mean Target N/A

52W Low$0.25 52W High$14.11

Current

Target

$0.25 $14.11

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG0025SKQ62

ISINUS45824Q8042

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.